Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Daniel Tassone und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Neoplasms, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Patients with inflammatory bowel disease (IBD) are at increased risk of malignancy and infection compared to the general population.
Aims
We aim to identify risk factors for malignancy or serious infection in our IBD cohort.
Methods
Patients with IBD from a single tertiary referral centre were included. Demographic and clinical details, including immunosuppressant exposure, were collected and medical records retrospectively screened for adverse events, including malignancy or infection requiring hospitalisation. Logistic regression was used to evaluate risk factors for adverse events.
Results
Five hundred and forty‐nine patients with IBD (340 Crohn disease (CD) and 209 ulcerative colitis (UC)) were studied. Forty‐eight malignancies, including 39 (81.3%) non‐melanoma skin cancers, 3 (6.3%) haematologic malignancies and 6 (15.4%) solid‐organ malignancies, were identified, and 92 cases of serious infection were detected. IBD duration (odds ratio (OR) = 1.08; 95% confidence interval (CI) = 1.03–1.13) and ileocolonic CD (OR = 4.96; 95% CI = 1.13–21.71) were associated with increased odds of overall cancer. Compared with patients not previously exposed to the given class of immunosuppression assessed, the development of overall malignancy was not higher with thiopurine exposure (OR = 1.00; 95% CI = 0.50–2.24) or anti‐tumour necrosis factor‐alpha (TNF‐α) exposure (OR = 0.78; 95% CI = 0.37–1.64). Similarly, compared with patients not exposed, infection risk was not affected by thiopurine (OR = 0.74; 95% CI = 0.46–1.20) or anti‐TNF exposure (OR = 0.60; 95% CI = 0.38–0.95).
Conclusions
Factors including ileocolonic CD and increasing IBD duration were associated with higher malignancy risk in this cohort. Compared with non‐exposure, patients exposed to thiopurines were not at increased risk of malignancy or serious infection. Similarly, patients exposed to anti‐TNF treatment did not experience increased rates of malignancy or serious infection compared to patients not exposed to this treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Daniel Tassone, Chamara Basnayake, Michael A Kamm, Ola Niewiadomski
Zitieren
APA
Tassone, D., Basnayake, C., Wright, E., Lust, M., Kamm, M. A., Niewiadomski, O., Schulberg, J., Flanagan, E., Samyue, T., Fry, S., Malcolm, R., Stanley, A., Thompson, A. J., Connell, W. R., & Ding, N. S. (2024). Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis. Internal Medicine Journal. https://doi.org/10.1111/imj.16141
Vancouver
Tassone D, Basnayake C, Wright E, Lust M, Kamm MA, Niewiadomski O, et al. Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis. Internal Medicine Journal. 2024. doi:10.1111/imj.16141
BibTeX
@article{Tassone2024,
author = {Tassone, Daniel and Basnayake, Chamara and Wright, Emily and Lust, Mark and Kamm, Michael A and Niewiadomski, Ola and Schulberg, Julien and Flanagan, Emma and Samyue, Tamie and Fry, Stephanie and Malcolm, Ruth and Stanley, Annalise and Thompson, Alexander J and Connell, William R and Ding, Nik S},
title = {Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16141}
}
EUVIMED